News
Research updates, company news, and insights into autoimmune diagnostics.
Research
•
May 14, 2026
Precision Medicine using Modular Genomics
A simple look at how RNA-based testing can help uncover patterns in immune system activity and support more informed care decisions.
Research
•
February 27, 2020
DxTerity Receives CE Mark for DxCollect® Fingerstick Blood RNA Stabilization Device
Learn how patient-friendly testing can reduce barriers, improve convenience, and help people stay more connected to their health journey.
•
May 18, 2022
DxTerity Receives New York Authorization for Type 1 Interferon (IFN-1) for Systemic Lupus Erythematosus
IFN-1 gene signature testing represents the advancement of precision medicine beyond cancer in autoimmune disease
All articles
View archive →
May 2023
COMPANY
5 gene interferon and Deucrava
OCT 2025
RESEARCH
Cenerimod ACR 2022 abstract
SEP 2025
RESEARCH
Characterizing Arthritis Subtypes in SL.
AUG 2025
COMPANY
Enpatoran SLE Eular 2025
JUL 2025
INDUSTRY
Morand IFN-1 High Longitudinal Analysis 2022
JUL 2025
INDUSTRY
Tuoma ACR IFN-1 abstract 2024
Connect with us
Discover how RNA-based diagnostics can provide the insights to better understand autoimmune diseases.
Learn more
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.
News
Research updates, company news, and insights into autoimmune diagnostics.
Research
•
May 14, 2026
Precision Medicine using Modular Genomics
A simple look at how RNA-based testing can help uncover patterns in immune system activity and support more informed care decisions.
Research
•
February 27, 2020
DxTerity Receives CE Mark for DxCollect® Fingerstick Blood RNA Stabilization Device
Learn how patient-friendly testing can reduce barriers, improve convenience, and help people stay more connected to their health journey.
•
May 18, 2022
DxTerity Receives New York Authorization for Type 1 Interferon (IFN-1) for Systemic Lupus Erythematosus
IFN-1 gene signature testing represents the advancement of precision medicine beyond cancer in autoimmune disease
All articles
View archive →
May 2023
COMPANY
5 gene interferon and Deucrava
OCT 2025
RESEARCH
Cenerimod ACR 2022 abstract
SEP 2025
RESEARCH
Characterizing Arthritis Subtypes in SL.
AUG 2025
COMPANY
Enpatoran SLE Eular 2025
JUL 2025
INDUSTRY
Morand IFN-1 High Longitudinal Analysis 2022
JUL 2025
INDUSTRY
Tuoma ACR IFN-1 abstract 2024
Connect with us
Discover how RNA-based diagnostics can provide the insights to better understand autoimmune diseases.
Learn more
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.